It plays a pivotal role in diseases including neurodegenerative disorders, inflammation, cancer, metabolic diseases, and cardiac conditions. As TREM2 detection is not AD-specific, combination of multiple biomarkers can be used for diagnosis of AD, and the diagnostic performance is better than single biomarker. Here, TREM2 is linked to metabolic disease.